glp 1 benefits beyond weight loss GLP-1 for and Diabetes GLP‑1 medications do more than

Vision Loss and NAION Concerns Non-arteritic anterior ischemic optic neuropathy (NAION) has emerged as a particularly devastating injury linked to GLP-1 medications, representing the second leading cause of optic nerve-related blindness in adults

Pierret ACS, Mizuno Y, Saunders P, et al

Furthermore, the stimulation of the endothelium, results in nitric oxide increases, and oxidative stress lowers for antiatherogenic and anti-inflammatory effects

The combination of antibiotic treatments and probiotic supplementation illustrates this synergy

Companies are racing to develop alternatives to injectable diabetes and weight loss drugs Injectable peptide drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have had massive impact on approaches to treating diabetes and obesity, bringing huge revenue boosts to makers Novo Nordisk and Eli Lilly

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimers disease: study protocol for a randomised controlled trial (ELAD study)